GRAMS: Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of Gadobutrol in Subjects with Known or Suspected Renal Artery Disease

The PI of this project was:

This project was funded by: Bayer

The term of this project was: May 2011 to September 2013

The number of subjects scanned during this project was: 15